(Q53478339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Joan Carles Galcerán

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Javier Hernandez-Losa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Santiago Ramon y Cajal

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

César Serrano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Cleofé Romagosa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Sara Simonetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Claudia Valverde

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Teresa Moliné

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Rosa Somoza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Manuel Pérez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ramona Vergés

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Rosa Domínguez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

19 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

99-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Mechanisms of sarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Targeting the RAF-MEK-ERK pathway in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

The biology behind mTOR inhibition in sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

The expanding TOR signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Phosphorylated 4E-BP1 is associated with poor survival in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Ras oncogenes: split personalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

RAS oncogenes: the first 30 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Prognostic significance of activated AKT expression in soft-tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Nuclear localization and regulation of erk- and rsk-encoded protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Improved survival with MEK inhibition in BRAF-mutated melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

The Akt/mammalian target of rapamycin pathway is activated and associated with adverse prognosis in soft tissue leiomyosarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

Cytogenetic intratumor heterogeneity in soft tissue tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

inferred from DOI database lookup

7 January 2021

based on heuristic

Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29733

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.29733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26479291%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference